Asherman's syndrome epidemiology and demographics: Difference between revisions
No edit summary |
No edit summary |
||
| Line 3: | Line 3: | ||
'''Editor(s)-in-Chief:''' {{CMG}} [[User:Csinfor|Canan S Fornusek, Ph.D.]]; '''Associate Editor-In-Chief:''' {{skhan}} | '''Editor(s)-in-Chief:''' {{CMG}} [[User:Csinfor|Canan S Fornusek, Ph.D.]]; '''Associate Editor-In-Chief:''' {{skhan}} | ||
==Overview== | ==Overview== | ||
<br /> | |||
==Epidemiology and Demographics== | ==Epidemiology and Demographics== | ||
The condition is estimated to affect 1.5% of women undergoing HSG <ref name="Dmowski">{{cite journal |author=Dmowski WP, Greenblatt RB. |title=Asherman’s syndrome and risk of placenta accreta |journal=Obstet Gynecol |volume=34 |issue=2 |pages=288–299. |year=1969 |pmid=5816312 |doi=}} | The true prevalence of Asherman’s syndrome is unclear. The condition is estimated to affect 1.5% of women undergoing HSG <ref name="Dmowski">{{cite journal |author=Dmowski WP, Greenblatt RB. |title=Asherman’s syndrome and risk of placenta accreta |journal=Obstet Gynecol |volume=34 |issue=2 |pages=288–299. |year=1969 |pmid=5816312 |doi=}} | ||
</ref>, between 5 and 39% of women with recurrent miscarriage <ref name="Rabau">{{cite journal |author=Rabau E, David A. |title=Intrauterine adhesions:etiology, prevention, and treatment |journal=Obstet Gynecol |volume=22 |pages=626–629. |year=1963 |pmid=14082285 |doi=}}</ref><ref name="Toaf">{{cite journal |author=Toaff R. |title=Some remarks on posttraumatic uterine adhesions.in French |journal=Rev Fr Gynecol Obstet |volume=61 |issue=7 |pages=550–552. |year=1966 |pmid=5940506 |doi=}} | </ref>, between 5 and 39% of women with recurrent miscarriage <ref name="Rabau">{{cite journal |author=Rabau E, David A. |title=Intrauterine adhesions:etiology, prevention, and treatment |journal=Obstet Gynecol |volume=22 |pages=626–629. |year=1963 |pmid=14082285 |doi=}}</ref><ref name="Toaf">{{cite journal |author=Toaff R. |title=Some remarks on posttraumatic uterine adhesions.in French |journal=Rev Fr Gynecol Obstet |volume=61 |issue=7 |pages=550–552. |year=1966 |pmid=5940506 |doi=}} | ||
</ref><ref name="Ventolini">{{cite journal |author=Ventolini G, Zhang M, Gruber J. |title=Hysteroscopy in the evaluation of patients with recurrent pregnancy loss: a cohort study in a primary care population |journal=Surg Endosc |volume=18 |issue=12 |pages=1782–1784. |year=2004 |pmid=15809790 |doi=10.1007/s00464-003-8258-y}}</ref> and up to 40% of patients who have undergone D&C for retained products of conception <ref name="Westendorp">{{cite journal |author=Westendorp ICD, Ankum WM, Mol BWJ, Vonk J. |title=Prevalence of Asherman’s syndrome after secondary removal of placental remnants or a repeat curettage for incomplete abortion |journal=Hum Reprod |volume=13 |issue=12 |pages=3347–3350. |year=1998 |pmid=9886512 |doi=10.1093/humrep/13.12.3347}} | </ref><ref name="Ventolini">{{cite journal |author=Ventolini G, Zhang M, Gruber J. |title=Hysteroscopy in the evaluation of patients with recurrent pregnancy loss: a cohort study in a primary care population |journal=Surg Endosc |volume=18 |issue=12 |pages=1782–1784. |year=2004 |pmid=15809790 |doi=10.1007/s00464-003-8258-y}}</ref> and up to 40% of patients who have undergone D&C for retained products of conception <ref name="Westendorp">{{cite journal |author=Westendorp ICD, Ankum WM, Mol BWJ, Vonk J. |title=Prevalence of Asherman’s syndrome after secondary removal of placental remnants or a repeat curettage for incomplete abortion |journal=Hum Reprod |volume=13 |issue=12 |pages=3347–3350. |year=1998 |pmid=9886512 |doi=10.1093/humrep/13.12.3347}} | ||
</ref>. | </ref>. It may occur in up to 13% of women undergoing a termination of pregnancy during the first trimester, and 30% in women undergoing a dilation and curettage (D and C) after a late '''spontaneous''' abortion. | ||
Women with placental abnormalities (e.g., placenta increta) may have a higher risk of developing Asherman syndrome as the placenta adheres to deeper layers within the uterus and becomes more difficult to remove. The incidence may be as high as 23.4% in patients undergoing procedures two to four weeks after the initial procedure for a vaginal delivery or missed abortion. The risk increases for patients undergoing repeated procedures for bleeding or repeated elective termination of pregnancies. | |||
It is found in 1.5% of women evaluated with a hysterosalpingogram (HSG) for infertility, between 5 and 39% of women with recurrent miscarriage. Asherman’s Syndrome may occur in 31% of women after the initial hysteroscopic resection of leiomyoma, and up to 46% after the second hysteroscopic resection. | |||
==References== | ==References== | ||
Revision as of 19:38, 27 June 2022
|
Asherman's syndrome Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Asherman's syndrome epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Asherman's syndrome epidemiology and demographics |
|
Asherman's syndrome epidemiology and demographics in the news |
|
Risk calculators and risk factors for Asherman's syndrome epidemiology and demographics |
Editor(s)-in-Chief: Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Canan S Fornusek, Ph.D.; Associate Editor-In-Chief: Saud Khan M.D.
Overview
Epidemiology and Demographics
The true prevalence of Asherman’s syndrome is unclear. The condition is estimated to affect 1.5% of women undergoing HSG [1], between 5 and 39% of women with recurrent miscarriage [2][3][4] and up to 40% of patients who have undergone D&C for retained products of conception [5]. It may occur in up to 13% of women undergoing a termination of pregnancy during the first trimester, and 30% in women undergoing a dilation and curettage (D and C) after a late spontaneous abortion.
Women with placental abnormalities (e.g., placenta increta) may have a higher risk of developing Asherman syndrome as the placenta adheres to deeper layers within the uterus and becomes more difficult to remove. The incidence may be as high as 23.4% in patients undergoing procedures two to four weeks after the initial procedure for a vaginal delivery or missed abortion. The risk increases for patients undergoing repeated procedures for bleeding or repeated elective termination of pregnancies.
It is found in 1.5% of women evaluated with a hysterosalpingogram (HSG) for infertility, between 5 and 39% of women with recurrent miscarriage. Asherman’s Syndrome may occur in 31% of women after the initial hysteroscopic resection of leiomyoma, and up to 46% after the second hysteroscopic resection.
References
- ↑ Dmowski WP, Greenblatt RB. (1969). "Asherman's syndrome and risk of placenta accreta". Obstet Gynecol. 34 (2): 288–299. PMID 5816312.
- ↑ Rabau E, David A. (1963). "Intrauterine adhesions:etiology, prevention, and treatment". Obstet Gynecol. 22: 626–629. PMID 14082285.
- ↑ Toaff R. (1966). "Some remarks on posttraumatic uterine adhesions.in French". Rev Fr Gynecol Obstet. 61 (7): 550–552. PMID 5940506.
- ↑ Ventolini G, Zhang M, Gruber J. (2004). "Hysteroscopy in the evaluation of patients with recurrent pregnancy loss: a cohort study in a primary care population". Surg Endosc. 18 (12): 1782–1784. doi:10.1007/s00464-003-8258-y. PMID 15809790.
- ↑ Westendorp ICD, Ankum WM, Mol BWJ, Vonk J. (1998). "Prevalence of Asherman's syndrome after secondary removal of placental remnants or a repeat curettage for incomplete abortion". Hum Reprod. 13 (12): 3347–3350. doi:10.1093/humrep/13.12.3347. PMID 9886512.